Chemed Co. (NYSE:CHE) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lowered its holdings in shares of Chemed Co. (NYSE:CHEFree Report) by 14.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 200,727 shares of the company’s stock after selling 33,047 shares during the period. Massachusetts Financial Services Co. MA owned 1.33% of Chemed worth $108,910,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of CHE. EntryPoint Capital LLC raised its position in Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after buying an additional 18 shares during the last quarter. Covestor Ltd raised its position in Chemed by 10.6% during the 1st quarter. Covestor Ltd now owns 219 shares of the company’s stock worth $141,000 after buying an additional 21 shares during the last quarter. Ballentine Partners LLC raised its position in Chemed by 3.4% during the 1st quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock worth $424,000 after buying an additional 22 shares during the last quarter. GAMMA Investing LLC raised its position in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares during the last quarter. Finally, Waterloo Capital L.P. raised its position in Chemed by 1.1% during the 4th quarter. Waterloo Capital L.P. now owns 2,252 shares of the company’s stock worth $1,317,000 after buying an additional 25 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director George J. Walsh III sold 200 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. The disclosure for this sale can be found here. Insiders sold 6,744 shares of company stock worth $3,828,231 in the last 90 days. 3.32% of the stock is currently owned by corporate insiders.

Chemed Stock Performance

Shares of Chemed stock opened at $577.59 on Thursday. The company has a market cap of $8.74 billion, a P/E ratio of 31.09, a PEG ratio of 2.31 and a beta of 0.44. Chemed Co. has a one year low of $497.36 and a one year high of $654.62. The firm has a fifty day moving average of $567.45 and a two-hundred day moving average of $578.35.

Chemed (NYSE:CHEGet Free Report) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The firm had revenue of $595.88 million for the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.71 EPS. As a group, equities analysts predict that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend was Monday, August 12th. This is an increase from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is currently 10.76%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.